Patents by Inventor Donald Heppner

Donald Heppner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090285879
    Abstract: Described are vaccine regimens in which specific prime/boost regimens are applied using low-neutralized recombinant adenoviral vectors harboring nucleic acids encoding antigens from Plasmodium falciparum and purified recombinant protein vaccines such as RTS,S, in the context of appropriate adjuvants.
    Type: Application
    Filed: December 23, 2008
    Publication date: November 19, 2009
    Applicants: Crucell Holland B.V., GlaxoSmithKline Biologicals S.A., on behalf of the Walter Reed Army Institute Research
    Inventors: Maria Grazia Pau, Jaap Goudsmit, Joseph D. Cohen, Patrice Dubois, V. Ann Stewart, Donald Heppner
  • Publication number: 20080131461
    Abstract: The invention relates to novel vaccine regimens in which specific prime/boost regimens are applied using low-neutralized recombinant adenoviral vectors harboring nucleic acids encoding antigens from Plasmodium falciparum and purified recombinant protein vaccines such as RTS,S, in the context of appropriate adjuvants.
    Type: Application
    Filed: October 13, 2005
    Publication date: June 5, 2008
    Applicants: Crucell Holland B.V., GlaxoSmithKline Biologicals S.A., The Government of the United States as Represented by the Secretary of the Army
    Inventors: Maria Grazia Pau, Jaap Goudsmit, Joseph D. Cohen, Patrice Dubois, V.Ann Stewart, Donald Heppner